All Pharma News
price-trendAsk Us
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology
PR NEWSWIRE
14 Feb 2024
Share Share
iNtRON, Executes Evaluation License and Option Agreement for SAL200

iNtRON, Executes Evaluation License and Option Agreement for SAL200
PR NEWSWIRE
30 Oct 2023
Share Share
iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM
PR NEWSWIRE
03 Sep 2023
Share Share
iNtRON identifies Prophage &Jamphage in the Pancreatic cancer related Microbiome

iNtRON identifies Prophage &Jamphage in the Pancreatic cancer related Microbiome
PR NEWSWIRE
29 May 2023
Share Share
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates
PRNEWSWIRE
11 Jul 2022
Share Share
iNtRON Completes GLP-TOX Studies of BAL200

iNtRON Completes GLP-TOX Studies of BAL200
PRNEWSWIRE
06 Jun 2022
Share Share
iNtRON Biotechnology, Inc., Launches New Website

iNtRON Biotechnology, Inc., Launches New Website
PRNEWSWIRE
09 May 2022
Share Share
Intron Bio secures new drug substance for bacterial pneumonia

Intron Bio secures new drug substance for bacterial pneumonia
S. Hyun-tai KOREABIOMEDICALREVIEW
23 Aug 2020
Share Share
Roivant joins forces with Korea’s iNtRON Bio to fight superbugs

Roivant joins forces with Korea’s iNtRON Bio to fight superbugs
21 Nov 2018
Share Share